31 results
424B3
BTTX
Better Therapeutics Inc
28 Dec 23
Prospectus supplement
9:23pm
from day-to-day activities, which may adversely affect management’s ability to oversee the development of our product candidates.
If we raise … oversee and conduct the study in compliance with GCP standards or are delayed for a significant time in the execution of the trial, including achieving full
8-K
EX-10.2
iafbnhto bzo2so2ngo
13 Dec 23
Entry into a Material Definitive Agreement
5:06pm
424B3
g7ik1 c162v0b8j
15 Nov 22
Prospectus supplement
9:56pm
424B3
mld7sybii62
11 Aug 22
Prospectus supplement
4:25pm
424B3
58ht7ibrrwk530 xc
7 Apr 22
Prospectus supplement
4:08pm
POS AM
whi ero3ud
1 Apr 22
Prospectus update (post-effective amendment)
4:25pm